Page 46
A n n u a l S u mm i t o n
Hepatology and Pancreatic
Diseases
November 12-13 , 2018
Par i s , France
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Hepatology and Pancreatic Diseases 2018
Introduction:
The hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver that typically occurs in the
setting of cirrhosis.
Methodology :
This retrospective and analytical study concerns 50patients (35men and15women) withhepatocellular carcinomas
post-cirrhosis C, collected from the Gastroenterology service of the Regional Military University Hospital of Constantine (HMRUC)
and the Gastroenterology and Oncology service of University Hospital of Constantine Ibn Badis - Algeria.
Results and discussion:
The averageage of the sample is 68.5 years with a sex ratio of M/W 2.33. The results indicated that
amino-transferases are 2-fold higher than normal in 78% of cases, these results are associated with an increase of GGT, PAL and
total bilirubin levels in 82%, 36% and 40% of cases respectively. An hypoalbuminemia was observed in 34 subjects, ie 68% and a
low prothrombin (TP) in 13 of the cases, ie 26%. Concerning underlying cirrhosis, half of the patients are classified as Child pugh
B. The medical imaging (ultrasound, MRI or CT) showed a nodular appearance observed in all cases, 24 of the patients (48%)
showed a solitary nodule whereas 13 of the subjects (36%) have diffuse nodules and 20 Patients (40%) have nodules located
on a single segment. The hepatocellular carcinoma is a severe disease, the prognosis of this ailment remains one of the worst,
because it is most often detected too late; it is generally discovered occasionally in diagnostic or examinations of chronic liver
disease.
sourayatebibel@yahoo.frEpidemiological - pathological
immunohistochemical study of hepatocellular
carcinoma in Algeria
Tabebibel Souraya
University Constantine, Algeria
J Clin Gastroenterol Hepatol 2018, Volume:2
DOI: 10.21767/2575-7733-C3-009




